CN101933992B - Powder for treating oral ulcer - Google Patents
Powder for treating oral ulcer Download PDFInfo
- Publication number
- CN101933992B CN101933992B CN2010102739062A CN201010273906A CN101933992B CN 101933992 B CN101933992 B CN 101933992B CN 2010102739062 A CN2010102739062 A CN 2010102739062A CN 201010273906 A CN201010273906 A CN 201010273906A CN 101933992 B CN101933992 B CN 101933992B
- Authority
- CN
- China
- Prior art keywords
- parts
- ulcer
- powder
- oral ulcer
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to powder for treating oral ulcer. The powder is prepared from the following raw materials in part by weight: 3 to 8 parts of medicinal cyathula root, 4 to 8 parts of tangerine peel, 3 to 6 parts of Chinese angelica, 2 to 5 parts of bupleurum, 3 to 6 parts of Chinese magnoliavine fruit, 0.1 to 1 part of borneol, 3 to 6 parts of chicken's gizzard-membrane, 2 to 6 parts of szechuan lovage rhizome, 1 to 4 parts of alum, 3 to 7 parts of liquoric root and 2 to 6 parts of angelica dahurlica. The powder of the invention has the advantages of having relatively obvious treatment effect for patients suffering from serious recurrent oral ulcer for a long time, fully improving immunologic function, enhancing the body resistance, killing ulcer viruses, curing ulcer and avoiding or eliminating recurrence for a relatively long time, along with simple composition, low cost and relatively ideal treatment effect.
Description
Technical field
The present invention relates to field of medicaments, relate in particular to a kind of powder of treating oral ulcer.
Background technology
Oral ulcer is called " aphtha " again, is the superficial ulcer that occurs on the oral mucosa, and big I is big or small, circular or oval from the grain of rice to Semen Glycines, and ulcer surface is recessed, congested on every side.Ulcer has characteristics such as periodicity, recurrent and self limiting, good sending out in lip, cheek, lingual margin etc.The cause of disease and mechanism of causing a disease are still indeterminate.Inducement possibly be local wound, psychentonia, food, medicine, hormonal readiness change and vitamin or trace element deficiency.Systemic disease, heredity, immunity and microorganism possibly play an important role in its generation, development.Treatment is main with topical therapeutic mainly, and severe patient needs whole body therapeutic.
At present, the cause of disease of oral ulcer and mechanism of causing a disease are still indeterminate.The inducement of oral ulcer possibly be local wound, psychentonia, food, medicine, hormonal readiness change and vitamin or trace element deficiency.Systemic disease, heredity, immunity and microorganism possibly play an important role in the generation of oral ulcer, development.Because etiology unknown, the diagnosis of oral ulcer is based on medical history and clinical manifestation fully, lacks to can be used as the lab index of making a definite diagnosis foundation.Oral ulcer is indicating that body has potential systemic disease, and like the disease of gastrointestinal, blood and hormonal system, but most of clinically patient body is healthy, the unsystematic disease.
Modern medicine thinks that recurrent oral ulceration at first has very confidential relation with immunity.The patient who has shows as immunodeficiency, and the patient who has then shows as autoimmune response, just because various factors, makes the normal immune system of human body, to autologous tissue's antigen, produces the immunity reflection, and causes disorganization and fall ill.Next is with heredity relation to be arranged, and in clinical, the morbidity of recurrent oral ulceration has tangible Inheritance tendency, and we usually see, father and mother one side or in many ways as if suffering from recurrent oral ulceration, so, their children are just ill more easily than common people.In addition, the outbreak of recurrent oral ulceration, usually also relevant with some diseases or symptom, such as the digestive system disease gastric ulcer; Duodenal ulcer, chronic or chronic persistent hepatitis, colitis etc., anemia in addition; Partial eclipse, dyspepsia, diarrhoea, heating; Do not have enough sleep, overtired, psychentonia, operating pressure is big, the change of menstrual cycle or the like.Along with one or more factors active, alternately, the overlapping immunity of organisms that just occurs descends, immunologic function disorder has also just caused the frequent of recurrent oral ulceration.
Chinese medicine has been widely used in the treatment oral ulcer at present.For example " surplus wheat oropharynx mixture ", this medicine is recurrence oral ulcer over-the-counter medications, and every bottled 100 milliliters, composition is Fructus Phyllanthi, Radix Rehmanniae etc., and adjuvant is a potassium sorbate, sucks a few minutes when taking usually to swallow better efficacy.But the exploitation for new medicine is never interrupted.
Summary of the invention
The purpose of this invention is to provide a kind of powder of treating oral ulcer.
In order to realize the object of the invention; The present invention provides a kind of powder of treating oral ulcer, and it is to be processed by following materials by weight: 2~6 parts of Radix Cyathulae 3-8 part, 4~8 parts of Pericarpium Citri Reticulataes, 3~6 parts of Radix Angelicae Sinensis, 2~5 parts of Radix Bupleuri, 3~6 parts of Fructus Schisandrae Chinensis, 0.1~1 part of Borneolum Syntheticum, 3~6 parts of Endothelium Corneum Gigeriae Galli, 2~6 parts of Rhizoma Chuanxiongs, 1~4 part of Alumen, 3~7 parts in Radix Glycyrrhizae and the Radixs Angelicae Dahuricae.
Preferably, the powder of treatment oral ulcer of the present invention is to be processed by following materials by weight: 4 parts of 5 parts of Radix Cyathulaes, 6 parts of Pericarpium Citri Reticulataes, 5 parts of Radix Angelicae Sinensis, 4 parts of Radix Bupleuri, 4 parts of Fructus Schisandrae Chinensis, 0.5 part of Borneolum Syntheticum, 6 parts of Endothelium Corneum Gigeriae Galli, 4 parts of Rhizoma Chuanxiongs, 2 parts of Alumens, 6 parts in Radix Glycyrrhizae and the Radixs Angelicae Dahuricae.
Can adopt method well known to those skilled in the art to carry out the preparation of powder.As required, can add various pharmaceutically acceptable carriers.Described carrier comprises the conventional diluent of pharmaceutical field, excipient, filler, binding agent, wetting agent, disintegrating agent, absorption enhancer, surfactant, absorption carrier, lubricant etc.Powder of the present invention in the preparation, selectable filler has: starch, Icing Sugar, calcium phosphate, dextrin, microcrystalline Cellulose, lactose, pregelatinized Starch, mannitol etc.; Selectable binding agent has: sodium carboxymethyl cellulose, PVP-K30, hydroxypropyl cellulose, starch slurry, methylcellulose, ethyl cellulose, hydroxypropyl emthylcellulose, gelling starch etc.; Selectable disintegrating agent has: dried starch, polyvinylpolypyrrolidone, cross-linking sodium carboxymethyl cellulose, carboxymethyl starch sodium, low-substituted hydroxypropyl cellulose etc.; Selectable lubricant has: magnesium stearate, Pulvis Talci, sodium lauryl sulphate, micropowder silica gel etc.
Component of the present invention is simple, with low cost; Therapeutic effect is more satisfactory, for the serious recurrent oral ulceration of long-term trouble apparent in view therapeutic effect is arranged, and can improve immunologic function comprehensively; The enhances human body resistance against diseases; Thereby eliminate ulcer virus, make the ulcer recovery from illness, and can in the long time, not recur or not send out.
The specific embodiment
Further specify the present invention through embodiment below.It should be understood that embodiments of the invention are to be used to explain the present invention rather than limitation of the present invention.The simple modifications that essence according to the present invention is carried out the present invention all belongs to the present invention and requires the scope protected.Except as otherwise noted, otherwise the percent among the present invention is percetage by weight.
Embodiment
Get Radix Cyathulae 50 grams, Pericarpium Citri Reticulatae 60 grams, Radix Angelicae Sinensis 50 grams, Radix Bupleuri 40 grams, Fructus Schisandrae Chinensis 40 grams, Borneolum Syntheticum 5 grams, Endothelium Corneum Gigeriae Galli 60 grams, Rhizoma Chuanxiong 40 grams, Alumen 20 grams, Radix Glycyrrhizae 60 grams and the Radix Angelicae Dahuricae 40 grams and fully mix, pulverize, cross 80 mesh sieves.Take by weighing Icing Sugar 30 grams then, cross 80 mesh sieves and above-mentioned raw materials and mix, promptly get.Gained powder is divided into 100 bags.
Experimental example
Trial drug: the powder of the medicine of the present invention of experimental example 1
Method for using: every day twice, each 1 bag evenly imposes on the ulcer.Two days courses of treatment, 3 courses of treatment of continuous administration.
Diagnostic criteria: 1, light-duty oral ulcer: the most common, account for 80%, general diameter 2-4mm, round or oval; Clear on every side, isolated being dispersed in, number is few, and each 1~5 is not waited; Good sending out in the relatively poor zone of keratinization degree, like lip cheek mucosa, the gum palatine that the keratinization degree is high is less, and ulcer has " recessed, red, yellow, bitterly " characteristic during outbreak; Be the ulcer concavity, substrate is not hard, and periphery is with the congested blush band of about 1mm, and the surface is covered with light yellow pseudomembrane; The causalgia sense is obvious, infects serious time companion's submandibular lymph nodes and swells and ache, and heating generally continues 1-2 week; Intermission is different in size, because of the thorn Severe Pain influences language, feed, mood, thereby quality of life is had a negative impact; 2, heavy oral ulcer: ulcer is big and dark during outbreak, and " like the crater " diameter 10-30mm reaches tela submucosa deeply until the flesh layer; The red and swollen protuberance of periphery, the substrate of laying one's hand on is harder, but neat in edge is clear; Normal single generation, stage of attack, can reach a month surplus even several months, and pain is heavier; More can stay cicatrix after, rare; 3, herpes appearance oral ulcer: ulcer is little, and diameter 2mm can reach more than the dozens of and many, but symptoms such as companioned with headache, low grade fever, general malaise, regional nodes's enlargement are rare.
Criterion of therapeutical effect: pain disappears, the oral ulcer surface healing.
The present invention is through clinical observation case 50 examples, wherein male 25 examples, and 37 years old mean age, women 25 examples, 38 years old mean age, the result shows: wherein 24 patients cured in one day, and 15 patients cured in two days, and 5 patients cured in three days, and 6 patients cured in four days.Total effective rate 100%.
Untoward reaction: do not see obvious adverse reaction.
Follow up a case by regular visits to the recurrence situation: follow the tracks of for the patient and followed up a case by regular visits to 2 months, all do not see recurrence.
Claims (1)
1. powder of treating oral ulcer; It is characterized in that it is to be processed by following materials by weight: 4 parts of 5 parts of Radix Cyathulaes, 6 parts of Pericarpium Citri Reticulataes, 5 parts of Radix Angelicae Sinensis, 4 parts of Radix Bupleuri, 4 parts of Fructus Schisandrae Chinensis, 0.5 part of Borneolum Syntheticum, 6 parts of Endothelium Corneum Gigeriae Galli, 4 parts of Rhizoma Chuanxiongs, 2 parts of Alumens, 6 parts in Radix Glycyrrhizae and the Radixs Angelicae Dahuricae.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010102739062A CN101933992B (en) | 2010-09-07 | 2010-09-07 | Powder for treating oral ulcer |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010102739062A CN101933992B (en) | 2010-09-07 | 2010-09-07 | Powder for treating oral ulcer |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101933992A CN101933992A (en) | 2011-01-05 |
CN101933992B true CN101933992B (en) | 2012-04-11 |
Family
ID=43387713
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010102739062A Expired - Fee Related CN101933992B (en) | 2010-09-07 | 2010-09-07 | Powder for treating oral ulcer |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101933992B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2637644C1 (en) * | 2016-12-26 | 2017-12-05 | Федеральное государственное бюджетное научное учреждение "Всероссийский научно-исследовательский институт лекарственных и ароматических растений" (ФГБНУ ВИЛАР) | Pharmaceutical, possessing a gastroprotective (antiulcer) activity |
CN112043673A (en) * | 2020-10-22 | 2020-12-08 | 海南森祺制药有限公司 | Nauclea officinalis extract spray composition and preparation method thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1380098A (en) * | 2002-05-20 | 2002-11-20 | 张勇飞 | Anti-infection compound preparation and its preparation method |
CN101428124B (en) * | 2007-11-05 | 2011-08-24 | 张忠美 | Preparation method of plaster for strongly improving phylactic power |
-
2010
- 2010-09-07 CN CN2010102739062A patent/CN101933992B/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN101933992A (en) | 2011-01-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100502936C (en) | Chinese medicinal compound preparation for inhibiting tumor and resisting insenescence | |
CN104623512A (en) | Mammary gland hyperplasia emplastrum | |
CN102657821B (en) | Drug for treating ovarian cyst | |
CN101259206B (en) | Medicine for curing oral ulcer | |
CN101933992B (en) | Powder for treating oral ulcer | |
CN1294015A (en) | Medicine for treating thyroid enlargement and thyroidism | |
CN105902558B (en) | A kind of pharmaceutical composition and its preparation method and application | |
CN102670892A (en) | Medicament for treating infantile diarrhea | |
CN102861199A (en) | Traditional Chinese medicine composition for treating gastroesophageal reflux disease and preparation method | |
CN102552511B (en) | Medicament for treating diarrhea | |
CN101279024A (en) | Chinese medicinal composition for treating anal fistula and method of preparing the same | |
CN1155380C (en) | Application of sophocarpidine oxide in preparing medicine to treat ulcerative colitis | |
CN1233364C (en) | Chinese medicine for treating digestive ulcerating sore and its preparation method | |
CN102600365B (en) | Drug for treatment of oral ulcers | |
CN1186042C (en) | Chinese medicine composition for curing AIDS and its preparation mehtod | |
CN1049148C (en) | Stomach-recovering capsule | |
CN1562232A (en) | Medication for curing ulcerationd of oral cavity | |
CN103735631B (en) | A kind of pharmaceutical composition for the treatment of hepatitis B and preparation method thereof | |
CN102657810B (en) | Medicament used for treating dyspepsia | |
CN1628770A (en) | Cough stopping and asthma relieving medicine and its preparation | |
CN102512652B (en) | Medicinal composition for treating peptic ulcer | |
CN102139016A (en) | Medlar floating tablet for treating chronic gastritis and preparation method thereof | |
CN1136873C (en) | Composite medicine for treating hyperglycaemia | |
CN100364596C (en) | Compounded mongolia medicine for treating diabetes and preparing method | |
CN100563679C (en) | The medicine of treatment hepatitis B great three positive, small three positive hepatopathy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120411 Termination date: 20120907 |